ABSTRACT A health survey was conducted on 199 workers engaged in dividing and packaging pyrethroids. The subjects were exposed to fenvalerate at 0O012-0055 mg/r3 and deltamethrin at--0005-0012 mg/m3 in the air with simultaneous skin contact for 0O5-4-5 months. Burning sensations and tightness or numbness on the face appeared in two thirds of the subjects and one third had sniffs and sneezes. Abnormal facial sensations, dizziness, fatigue, and miliary red papules on the skin were more evident in summer than in winter. Neither abnormalities in other organs or systems nor symptoms or signs of acute pyrethroid poisoning were found by interviews, examinations, and laboratory tests. There was no significant difference in plasma levels of NA, cAMP, and cGMP between the examined subjects and the control group. The urine concentration of fenvalerate in the study group ranged from 1 02 to 18-6 yg/l; deltamethrin in the urine was present in trace amounts.
study group ranged from 1 02 to 18-6 yg/l; deltamethrin in the urine was present in trace amounts.
Importation and application ofpyrethroid insecticides for pest control in China have increased. By comparison with commonly applied broad spectrum insecticides such as organophosphates and carbamates, synthetic pyrethroids have a high insecticidal activity and a low toxicity in mammals. They are rapidly metabolised and leave virtually no residue in the biosphere.' They are therefore used to control a wide variety of agricultural pests and to protect stored products. At present, the most popularly used pyrethroids in cotton fields are deltamethrin, fenvalerate, and cypermethrin. To facilitate the application of these insecticides by individual farmers, the imported barrelled pyrethroids are divided and packaged into 100 ml bottles in several small pesticide factories. Since there is little information concerning human chronic exposure to synthetic pyrethroids, the purpose of the present study was to investigate the effects of pyrethroids on occupationally exposed subjects engaged in dividing and packaging pyrethroid insecticides.
Material and methods EXPOSURE BACKGROUND
Work procedure The whole process ofdividing, packaging, and repackAccepted 14 August 1987 aging pyrethroids was completed by hand. The imported barrelled 2-5% deltamethrin emulsion (RousselUclaf Company), 20% fenvalerate emulsion (Suimoto Company), or 10% cypermethrin emulsion (Shell Oil Company) were alternately poured into containers from which the pyrethroid emulsion flowed through rubber tubes to fill 100 ml bottles. About 50000 bottles a day were filled up and packed in boxes. All work was conducted over a period of four to five months on two occasions-in late winter and during the summer. The workers wore rubber gloves and gauze masks only in winter and had more cutaneous exposure in summer to pyrethroids, mainly fenvalerate and deltamethrin. There was no mechanical ventilation or air conditioning in the workshops. The air concentration of the solvent vehicle (xylene) was lower than 100 mg/m3 but the smell of xylene could be detected.
Analyses offenvalerate and deltamethrin in air samples Air was sampled two to 12 times for each sampling place in two workshops with an air flow of 2-10 I/min in 1983 and 1984. Fenvalerate and deltamethrin in air were collected on polyester or glass fibre filters and then extracted with n-hexane and determined by gas chromatography with 63 Ni electron capture detector. A varian 3700 gas chromatograph was used equipped with a 3% OV-101/Chromosob WAW DMCS 60-80 mesh, 1 m ± 2 mm column at 240°C. The detection limit was 2 ng/ml hexane. 548
Effects ofpyrethroid insecticides on subjects engaged in packaging pyrethroids 
Methods
Clinical examination-All subjects were interviewed and given questionnaires about their occupational history, past illness, previous exposure to pesticides, and present symptoms. Physical and neurological examinations, electrocardiogram and laboratory tests including blood haemoglobin and white cell count, routine urine tests, and serum glutamic pyruvic transaminase were carried out. Further investigations included (a) radioenzymatic assay of plasma noradrenaline (NA) in 27 controls and 73 subjects of the winter group, among whom 70% had been exposed for at least four months; and (b) radioimmunoassay for plasma guanosine 3', 5'-cyclic phosphate (cGMP) and cyclic aminomonophosphate (cAMP) in five controls and 10 subjects exposed to pyrethroids randomly chosen from those having been examined on plasma NA.
Analyses offenvalerate and deltamethrin in urineTwenty four hour urine or morning urine samples were collected in polyvinyl bottles rinsed by I N HCL from 22 subjects during exposure to fenvalerate or deltamethrin. A Beckman 344 high performance liquid chromatograph with a detection limit at 4 ig/l was used for the analysis of deltamethrin in seven workers. The same gas chromatographic system as described above was used for analysis of urinary fenvalerate in five workers and for analyses of both urine deltamethrin and fenvalerate (detection limit of both were 0-2 pg/l using 10 ml urine sample) in 10 workers. Table 2 shows the results of determination of fenvalerate and deltamethrin in air samples.
Results

AIR CONCENTRATION OF PYRETHROIDS
CLINICAL FEATURES
Two thirds of the subjects from both groups exposed to pyrethroids developed abnormal facial sensation that was described as feelings of burning, tingling, itching, tightness, or numbness (table 3) . The facial sensory symptoms in most cases (107 subjects) appeared after half an hour's exposure and lasted no longer than 24 hours. The cheeks and periorbital areas were most frequently and symmetrically affected despite wearing gauze masks. The facial burning or tingling sensation was often exacerbated by sweating or washing with warm water. Sneezing and increased nasal secretion were also temporarily present at work and were more often seen in the winter group.
Systemic symptoms such as dizziness, fatigue, or nausea were subtle or mild. On examination, red miliary papules with mild itching were found in 14-1% of the subjects mainly on the face and chest, occasionally on the girdle area and perineum, but seldom on the hands. The abnormal facial sensation, dizziness, and fatigue and the red miliary papules were all more frequently seen in the summer group than the winter group (p < 0 05).
The 44 workers who had had previous exposure to deltamethrin or fenvalerate in fields or workshops and had had transient abnormal facial sensation six months before developed similar symptoms during current exposure. But in only one of the five subjects who had previously had miliary papules due to exposure to pyrethroids did the skin changes appear.
There were no clinical signs of acute pyrethroid poisoning such as headache, fasiculations, and convulsions (F He et al, XXI International Congress on The levels of plasma NA, cGMP, and cAMP in the exposed subjects were all in the normal range compared with the reference group (table 4).
BIOLOGICAL MONITORING
The amount of fenvalerate in urine determined in five workers exposed to fenvalerate at 0 055 ± 0-013 mg/m3 for 4-5 months was 1 02-186 ig/l by gas chromatography. After cessation of dividing and packaging fenvalerate for five days, the urinary fenvalerate was still detectable at 0-2-0-7 ug/l in eight out of 10 workers, although the air concentration of fenvalerate was 0 013 i 0-004 mg/m3. Urinary deltamethrin concentrations in 17 exposed subjects were in trace amounts using either gas chromatography or high performance liquid chromatography (table 5) .
Discussion
The increased use of pyrethroid insecticides in recent years has established them as a major class of pesticide chemicals. Yet few data are to be found concerning the ffects ofhuman exposure. Le Quesne and Maxwell first reported that 19 of 23 workers exposed to cypermethrin, permethrin, and fenvalerate experienced episodes of abnormal facial sensation without neurological and (F He, 1984) and dermatitis with vesiculation and red miliary papules due to exposure to deltamethrin in farmers were reported in China.
In the present study the most prominent symptom in subjects engaged in dividing and packaging fenvalerate, deltamethrin, and cypermethrin was transient abnormal facial sensation. The second symptom was sneezing or increased nasal secretion. The systemic symptoms were mild and the red itching miliary papules were the only abnormal signs in 14% of the exposed subjects. Although the air concentration of pyrethroids in the dividing and packaging workshops was lower in the summer than in the winter because of increased ventilation by opening the doors and windows, the facial sensory symptoms, systemic symptoms, and skin papules were more often seen in subjects in the summer group. This may be due to more cutaneous exposure to pyrethroids in summer because the workers did not use protective gloves for climatic reasons and tended to sweat more. The rashes that occasionally appeared on the girdle area or perineum seemed to result from direct topical skin contact with pyrethroids from contaminated hands.
It is of interest to ascertain whether the burning and tingling facial sensation reported by the exposed subjects was an irritative skin reaction or a sign of peripheral sensory nerve involvement. In most of our subjects this sensory symptom was noted mainly on the face but not on the hands and other exposed areas and was not associated with papules. There was about a 30 minute latent period for the development of the sensation and it generally lasted no longer than 24 hours. Moreover, direct contact with the pyrethroid emulsion was not necessary to induce the paraesthaesias. All Cremer and Seville reported that the type 2 syndrome, partic larly choreoathetotic writhing induced by deltamethra n in rat, was associated with unusually high concenti ations of plasma noradrenaline and adrenalin co ared with other stressful conditions.7 Cerebellar cG P was also raised to 10 times those in control anim ls during the deltamethrin induced motor syndr me.8 In the present study neither manifestation of acute pyrethroid poisoning nor significant cha ages of plasma NA, cGMP, and cAMP were found.
In five wor ers exposed to fenvalerate at levels of 0 055 ± 0-0134 mg/m3 with simultaneous skin contact with the same pyrethroids for 0-5-4 5 months urinary fenvalerate le els determined by gas chromatography were 1-02-18-5 pg/l. When the air concentration of fenvalerate w s lowered to 0-01 3 ± 0-004 mg/m3 after the dividing a d packaging of fenvalerate was stopped for five days, the urinary fenvalerate concentration was still detec table at 0-2-0-7 ug/l in eight of the 10 workers. This ndicates that it is necessary to minimise exposure. By contrast, all the urinary deltamethrin concentration determined in 17 exposed workers were lower than the detection limit of both gas chromatography (0-2 pg/I) and high performance liquid chromatography (4 pg/l). The reason for this, other than lower air concentration of deltamethrin, is the rapid metabolism of deltamethrin. Ruzo et al showed that 98-99% of deltamethrin was excreted in rats on the eighth day after dosing9; it is advisable to develop methods for measuring metabolites of deltamethrin in the urine'" to investigate the uptake and metabolism of deltamethrin in man further.
